IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 801–900 of 1,002
The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment
Snyder, R. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12333 · Cited by 16
CD8+ T cells drive autoimmune hematopoietic stem cell dysfunction and bone marrow failure
Gravano, D. M., Al-Kuhlani, M., Davini, D. W., Sanders, P. D., Manilay, J. O., & Hoyer, K. K. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.07.007 · Cited by 19
The chromatin-associated Sin3B protein is required for hematopoietic stem cell functions in mice
Cantor, D. J., & David, G. (2016) · Blood · doi:10.1182/blood-2016-06-721746 · Cited by 19
Development of the hematopoietic system: Role of inflammatory factors
Hayashi, Y., Sezaki, M., & Takizawa, H. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.341 · Cited by 19
“Likewise, adult murine HSCs have been reported to respond directly to IFN-α through their respective receptors and are recruited from dormancy to active proliferation (Essers et al., 2009; Sato et al., 2009).”
BackgroundA Curative DNA Code for Hematopoietic Defects
Porteus, M. H., Pavel-Dinu, M., & Pai, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.05.002 · Cited by 18
López, D. A., Otsuka, K., Apostol, A. C., Posada, J., Sánchez‐Arcila, J. C., Jensen, K. D. C., & Beaudin, A. E. (2023) · The EMBO Journal · doi:10.15252/embj.2022112693 · Cited by 17
“The EMBO Journal 42: e112693 | 2023 1 of 16 (Essers et al, 2009; Baldridge et al, 2010; Matatall et al, 2014; Haas et al, 2015).”
BackgroundInfluentialExploring extramedullary hematopoiesis: unraveling the hematopoietic microenvironments
Rivera-Torruco, G., Muench, M. O., & Valle‐Rios, R. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1371823 · Cited by 20
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development
Thambyrajah, R., Maqueda, M., Fadlullah, M. Z. H., Proffitt, M., Neo, W. H., Guillén, Y., Casado-Peláez, M., Molinero, P. H., Brujas, C., Castelluccio, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48854-5 · Cited by 16
Cellular stress and epigenetic regulation in adult stem cells
Llewellyn, J., Baratam, R., Čulig, L., & Beerman, I. (2024) · Life Science Alliance · doi:10.26508/lsa.202302083 · Cited by 18
Maintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition
Williams, M., Wang, X., Bastos, H. P., Grondys-Kotarba, G., Johnson, C., Mende, N., Calderbank, E. F., Wantoch, M., Park, H. J., Wu, Q., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014046 · Cited by 19
Wang, J., Zhang, L., Cui, X., Xu, X., Guo, R., Li, K., Zhang, L., Xu, B., Jiang, C., & Yu, Y. (2025) · Science Immunology · doi:10.1126/sciimmunol.adr2041 · Cited by 17
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal
Xu, J. J., Smeets, M. F. M. A., Tan, S. Y., Wall, M., Purton, L. E., & Walkley, C. R. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.001 · Cited by 15
Usp22 is an intracellular regulator of systemic emergency hematopoiesis
Dietlein, N., Wang, X., Metz, J., Disson, O., Shang, F., Beyersdörffer, C., Rodriguez-Correa, E., Lipka, D. B., Begus‐Nahrmann, Y., Kosinsky, R. L., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq2061 · Cited by 15
Myeloprotection by Cytidine Deaminase Gene Transfer in Antileukemic Therapy
Lachmann, N., Brennig, S., Phaltane, R., Flaßhove, M., Dilloo, D., & Moritz, T. (2013) · Neoplasia · doi:10.1593/neo.121954 · Cited by 16
Ghosh, J., & Kapur, R. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0067-z · Cited by 16
New genetic tools for the in vivo study of hematopoietic stem cell function
Upadhaya, S., Reizis, B., & Sawai, C. M. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.02.004 · Cited by 17
Garton, J. W., Barron, M. D., Ratliff, M., & Webb, C. F. (2019) · Cells · doi:10.3390/cells8101136 · Cited by 16
Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies
Kilmister, E. J., Hansen, L., Davis, P. F., Hall, S. R. R., & Tan, S. T. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2020.610758 · Cited by 15
“This is significant as the STAT family consists of intracellular signaling molecules with multiple influences on stem cell populations, particularly hematopoietic stem cells (95).”
BackgroundYoon, K.-A., Son, Y., Choi, Y.-J., Kim, J., & Cho, J.-Y. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0181-2 · Cited by 13
Conditionally pathogenic genetic variants of a hematopoietic disease-suppressing enhancer
Soukup, A. A., Matson, D. R., Liu, P., Johnson, K. D., & Bresnick, E. H. (2021) · Science Advances · doi:10.1126/sciadv.abk3521 · Cited by 15
“…system requires the Ets motif to respond to the viral mimetic polyinosinic:polycytidylic acid (polyI:C or pI:C), which induces a type I interferon response and transition of quiescent to proliferative long-term (LT)–HSCs ( 36 ), and whether the motif variant compromises cell cycle entry.”
G2 arrest primes hematopoietic stem cells for megakaryopoiesis
Garyn, C. M., Bover, O., Murray, J. W., Ma, J., Salas-Briceno, K., Ross, S. R., & Snoeck, H.-W. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114388 · Cited by 14
Akkermansia muciniphila induces slow extramedullary hematopoiesis via cooperative IL‐1R/TLR signals
Wang, Y., Morishima, T., Sezaki, M., Sato, R., Nakato, G., Fukuda, S., Kobiyama, K., Ishii, K. J., Li, Y., & Takizawa, H. (2023) · EMBO Reports · doi:10.15252/embr.202357485 · Cited by 15
“One of the HSPC defining markers, Sca-1 (Essers et al , 2009) is the interferon (IFN)-responsive genes known to be upregulated upon bacterial infection (Essers et al , 2009), and may cause overes-timation of HSPC number (Umemoto et al , 2017) due to a contamination of Sca-1 negative LK into LSK…”
InfluentialYin Yang 1 regulates cohesin complex protein SMC3 in mouse hematopoietic stem cells
Lu, Z., Wang, Y., Assumpção, A. L. F. V., Liu, P., Kopp, A., Saka, S., McIlwain, S. J., Viny, A. D., Brand, M., & Pan, X. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011411 · Cited by 16
Hematopoietic stem cell a reservoir of innate immune memory
Ruffinatto, L., Groult, Y., Iacono, J., Sarrazin, S., & de Laval, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1491729 · Cited by 15
Clonal hematopoiesis landscape in frequent blood donors
Karpova, D., Encabo, H. H., Donato, E., Calderazzo, S., Scherer, M., Llorian, M., Leppä, A., Würth, R., Stelmach, P., Papazoglou, D., et al. (2025) · Blood · doi:10.1182/blood.2024027999 · Cited by 18
Self-citationLv, H., Wang, C., Liu, Z., Quan, M., Li, K., Gou, F., Shi, X., Liu, Q., Yu, Y., Zhu, P., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.069420 · Cited by 17
Azrak, S., Ginel-Picardo, A., Drosten, M., Barbacid, M., & Santos, E. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-731 · Cited by 15
Bego, M. G., Miguet, N., Laliberté, A., Aschman, N., Gérard, F. C. A., Merakos, A. A., Weissenhorn, W., & Cohen, É. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008481 · Cited by 14
Cutaneous extramedullary haematopoiesis: Implications in human disease and treatment
Khalil, S., Gru, A. A., & Saavedra, A. P. (2019) · Experimental Dermatology · doi:10.1111/exd.14013 · Cited by 15
IRF7 suppresses hematopoietic regeneration under stress via CXCR4
Chen, Y., Liu, Y., Liu, Y., Deng, X., & Zhou, J. (2020) · Stem Cells · doi:10.1002/stem.3308 · Cited by 15
“Upregulation of stem cell antigen-1 (Sca-1) and increased phosphorylation of STAT1 and PKB/Akt represented the mechanism.(9,11) IRF2, the negative regulator of type I IFN signaling, preserves the self-renewal and multilineage differentiation capacity of HSCs.”
BackgroundKatagiri, T., Uemura, S., Ushiki, T., Nakajima‐Takagi, Y., Oshima, M., Mikami, T., Kawasaki, A., Ishiguro, H., Tanaka, T. N., Sone, H., et al. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.02.003 · Cited by 14
Ju, Q., Huang, T., Zhang, Y., Wu, L., Geng, J., Mu, X., Yan, T., & Zhang, J. (2021) · Medicine · doi:10.1097/md.0000000000024640 · Cited by 16
PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS‐STING‐Mediated Interferon Response
Geng, X., Zhang, C., Li, M., Wang, J., Ji, F., Feng, H., Xing, M., Li, F., Zhang, L., Li, W., et al. (2022) · Advanced Science · doi:10.1002/advs.202103837 · Cited by 15
Resolving the hematopoietic stem cell state by linking functional and molecular assays
Jassinskaja, M., Gońka, M., & Kent, D. G. (2023) · Blood · doi:10.1182/blood.2022017864 · Cited by 17
Hematopoietic stem cells, infection, and the niche
Prendergast, Á. M., & Essers, M. A. G. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12400 · Cited by 14
Self-citationImmunoregulatory Effects of Interferon-β in Suppression of Th17 cells
Pennell, L. M., & Fish, E. N. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0088 · Cited by 15
Molecular pathogenesis of tyrosine kinase resistance in chronic myeloid leukemia
Rosée, P. G. L., & Hochhaus, A. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283366be1 · Cited by 14
Med23 serves as a gatekeeper of the myeloid potential of hematopoietic stem cells
Chen, X., Zhao, J., Gu, C., Cui, Y., Dai, Y., Song, G., Liu, H., Shen, H., Liu, Y., Wang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06282-2 · Cited by 16
A20 deficiency in multipotent progenitors perturbs quiescence of hematopoietic stem cells
Nakagawa, M. M., Davis, H., & Rathinam, C. V. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.10.020 · Cited by 15
“Based on the previous findings (Baldridge et al., 2010; Baldridge et al., 2011; Essers et al., 2009; King and Goodell, 2011; Mirantes et al., 2014; Sato et al., 2009), including our own (Nakagawa et al., 2015), on the critical role of inflammatory cytokines in HSC quiescence, we have hypothesized…”
BackgroundResultVarlamov, O., Bucher, M., Myatt, L., Newman, N., & Grant, K. A. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14328 · Cited by 14
“HSPCs exist in a quiescent state but can proliferate and differentiate in mature blood cells in response to injury and infection (Wilson et al., 2008, Essers et al., 2009, Baldridge et al., 2010).”
BackgroundZhang, C., Jin, N., Gao, F., Sun, D., Zhou, C., Cheng, Y., Cai, J., & Li, B. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00695.x · Cited by 14
Hematopoietic Stem Cells and Regeneration
Biermann, M., & Reya, T. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040774 · Cited by 16
Novel approaches to target cancer initiating cells–Eliminating the root of the cancer
McCubrey, J. A., Abrams, S. L., Umezawa, K., Cocco, L., Martelli, A. M., Franklin, R. A., Chappell, W. H., & Steelman, L. S. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.011 · Cited by 13
Du, L., Freitas-Cortez, M. A., Zhang, J., Xue, Y., Veettil, R. T., Zhao, Z., & Morrison, S. J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412317122 · Cited by 21
How stem cells respond to infection, inflammation and ageing
Poirier, E. Z. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01203-z · Cited by 16
Basal IFN-λ2/3 expression mediates tight junction formation in human epithelial cells
Keser, Y., Metz‐Zumaran, C., Uckeley, Z. M., Reuss, D., Doldan, P., Ramsden, J. M., Stanifer, M. L., & Boulant, S. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00539-5 · Cited by 14
“Basal expression of type I IFN (IFN β ) is known to have multiple biological roles such as maintaining the hematopoietic stem cell niche (Essers et al, 2009) and regulating immune cell function (Ganal et al, 2012) and bone remodeling (Deng et al, 2020).”
Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer
Chen, C., Man, N., Liu, F., Martín, G. M., Itonaga, H., Sun, J., & Nimer, S. D. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3503 · Cited by 13
Seung, H., Wrobel, J., Wadle, C., Bühler, T., Chiang, D., Rettkowski, J., Cabezas‐Wallscheid, N., Hechler, B., Stachon, P., Maier, A., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00927-6 · Cited by 14
Zheng, Q., Cao, J., Hamad, N., Kim, H., Moon, J. H., Sohn, S. K., Jung, C. W., Lipton, J. H., & Kim, D. D. H. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0837-5 · Cited by 13
“A recent study demonstrated that IFN-alpha treatment promotes proliferation of dormant HSCs, increasing the chance of G0 cells entering into the active cell division cycle [24].”
BackgroundChronic Myeloid Leukemia: Immunobiology and Novel Immunotherapeutic Approaches
Cayssials, É., & Guilhot, F. (2017) · BioDrugs · doi:10.1007/s40259-017-0225-6 · Cited by 13
“These primitive LSCs are insensitive to TKIs, making them difficult to eradicate [5, 6].”
BackgroundInfluentialAre transplantable stem cells required for adult hematopoiesis?
McRae, H. M., Voss, A. K., & Thomas, T. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.05.007 · Cited by 13
mTORC1 activity is essential for erythropoiesis and B cell lineage commitment
Malik, N., Dunn, K. M., Cassels, J. E., Hay, J., Estell, C., Sansom, O. J., & Michie, A. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-53141-1 · Cited by 14
Howard, J. E., Smith, J. N. P., Fredman, G., & MacNamara, K. C. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.011 · Cited by 15
“In models of sterile inflammation, transient, acute IFN-a induced proliferation of typically quiescent HSCs in vivo (Essers et al., 2009).”
BackgroundKubota, S., Sun, Y., Morii, M., Bai, J., Ideue, T., Hirayama, M., Sorin, S., Eerdunduleng, E., Yokomizo‐Nakano, T., Osato, M., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00122-4 · Cited by 14
“…such as infection, in fl ammation, and myeloablation, and expand hematopoietic stem and progenitor cells (HSPCs) to produce mature blood cells (Essers et al, 2009; Baldridge et al, 2010; Haas et al, 2015); however, the mechanisms by which HSCs maintain hematopoiesis based on their…”
BackgroundA new chapter: hematopoietic stem cells are direct players in immunity
Zheng, J., Song, C. X., & Zhang, C. C. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-33 · Cited by 13
“Several classes of signaling receptors expressed on HSCs that bind to cytokines or infectious ligands directly participate in the infection response: IFN receptors [25-27], TNF receptor [28-30], and Tolllike receptors (TLR) [31-33] (see review by Goodell’s group [34]).”
BackgroundHerd, O., Rani, G. F., Hewitson, J. P., Hogg, K., Stone, A. P., Cooper, N., Kent, D. G., Genever, P. G., & Hitchcock, I. S. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003887 · Cited by 13
Veizades, S. A., Tso, A., & Nguyen, P. K. P. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0348 · Cited by 15
A culture platform to study quiescent hematopoietic stem cells following genome editing
Shiroshita, K., Kobayashi, H., Watanuki, S., Karigane, D., Sorimachi, Y., Fujita, S., Tamaki, S., Haraguchi, M., Itokawa, N., Aoyama, K., et al. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100354 · Cited by 13
Yokomizo‐Nakano, T., Hamashima, A., Kubota, S., Bai, J., Sorin, S., Sun, Y., Kikuchi, K., Iimori, M., Morii, M., Kanai, A., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220962 · Cited by 12
“…in BM after 2 wk from that in naive cells, but significantly compromised hematopoiesis in the long term, which is consistent with previous findings on the effects of inflammatory stress on HSCs using various infection stimuli (Essers et al., 2009; Baldridge et al., 2010; Takizawa et al., 2017).”
InfluentialSingle-cell time series analysis reveals the dynamics of HSPC response to inflammation
Bouman, B. J., Demerdash, Y., Sood, S., Grünschläger, F., Pilz, F., Itani, A. R., Kuck, A., Marot-Lassauzaie, V., Haas, S. F., Haghverdi, L., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302309 · Cited by 17
“Using conventional marker-based fl ow cytometryincludingSca-1,anincrease inthe more stem-likeLSK(Lin − Sca-1 + cKit + ) cells and a decrease in the more committed LS − K (Lin − Sca-1 − cKit + ) progenitors is observed in response to in fl ammation (Fig 1C –”
BackgroundResultInfluentialSelf-citationAskenasy, N. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.002 · Cited by 12
“IFNα prompts exit of quiescent progenitors from the Go phase and signaling through the STAT pathway induces gene expression including stem cell antigen (SCA-1) [22].”
BackgroundInfluentialNishiyama‐Fujita, Y., Shimizu, T., Sagawa, M., Uchida, H., & Kizaki, M. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.05.008 · Cited by 12
Chen, M. J., da Rocha, E. L., Cahan, P., Kubaczka, C., Hunter, P., Sousa, P. M., Mullin, N. K., Fujiwara, Y., Nguyen, M., Tan, Y., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.020 · Cited by 12
Global dynamics of healthy and cancer cells competing in the hematopoietic system
Andersen, M., Hasselbalch, H. C., Kjær, L., Skov, V., & Ottesen, J. T. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108372 · Cited by 12
“Altering β2 by decreasing ry and increasing rx corresponds to a mechanism of the drug where the malignant clone is targeted [70,72] and HSC are activated [73].”
BackgroundRitter, M. U., Klimiankou, M., Klimenkova, O., Schambach, A., Hoffmann, D., Schmidt, A. P., Kanz, L., Link, D. C., Welte, K., & Skokowa, J. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04194-0 · Cited by 12
Wu, M.-S., Kuo, Y.-P., Lo, Y.-C., Tsai, D.-J., Lai, C.-Y., Chuang, T., Lin, S., Tsai, W.-T., Chung, P., & Yu, G. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.03.006 · Cited by 13
Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells
Li, Y., & Magee, J. A. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.07.004 · Cited by 14
Does EBV alter the pathogenesis of malaria?
Matar, C. G., Jacobs, N. T., Speck, S. H., Lamb, T. J., & Moormann, A. M. (2015) · Parasite Immunology · doi:10.1111/pim.12212 · Cited by 12
Analysis of Murine Hematopoietic Stem Cell Proliferation During Inflammation
Jalbert, E., & Pietras, E. M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7371-2_14 · Cited by 12
MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets
Mian, Y. A., & Zeleznik‐Le, N. J. (2010) · Current Drug Targets · doi:10.2174/138945010791320872 · Cited by 13
Patel, B., Zhou, Y., Babcock, R. L., Ma, F., Zal, M. A., Kumar, D., Medik, Y. B., Kahn, L. M., Pineda, J. E., Park, E. M., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02218-6 · Cited by 15
Striking the right balance with type I interferon signalling in cancer
Chadwick, T. B., So, J., Hertzog, P. J., Haynes, N. M., & Parker, B. S. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00915-1 · Cited by 16
“Examples of this plasticity include IFNα-mediated activation of haematopoietic stem cells 56 and induction of the IFN-related DNA damage resistance signature (IRDS) after genotoxic stress 57 .”
Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice
Duyvestyn, J. M., Taylor, S. J., Dagger, S. A., & Langdon, W. Y. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.02.008 · Cited by 11
He, Q., & Liu, F. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000197 · Cited by 12
Stalmann, U., Ticconi, F., Snoeren, I., Li, R., Gleitz, H. F. E., Cowley, G. S., McConkey, M. E., Wong, A. B., Schmitz, S., Fuchs, S. N. R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006061 · Cited by 12
Self-citationHuang, L., Li, F., Ye, L., Yu, F., & Wang, C. (2023) · Cell Proliferation · doi:10.1111/cpr.13413 · Cited by 11
Lin, S., Lin, K.-M., Chen, S.-Y. J., Ku, C., Huang, C., Huang, C., Gale, M., & Tsai, C.-H. A. (2023) · Journal of Virology · doi:10.1128/jvi.00102-23 · Cited by 12
Kumar, P., Zhang, N., Lee, J., Cheng, H., Kurtz, K. J., Conneely, S. E., Sasidharan, R., Rau, R. E., & Pati, D. (2023) · Stem Cells · doi:10.1093/stmcls/sxad058 · Cited by 11
Chronic exposure to IFNα drives medullar lymphopoiesis towards T-cell differentiation in mice
Scala, M. D., Gil-Fariña, I., Vanrell, L., Sánchez-Bayona, R., Alignani, D., Olagüe, C., Vales, Á., Berraondo, P., Prìeto, J., & González‐Aseguinolaza, G. (2015) · Haematologica · doi:10.3324/haematol.2014.115410 · Cited by 13
The one-two punch: Combination treatment in chronic myeloid leukemia
Sweet, K. L., Hazlehurst, L., & Pinilla-Ibarz, J. A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.017 · Cited by 13
“These clinical observations, in light of prelinical findings that exposure to interferon alfa can activate uiescent hematopoietic stem cells in a mouse model [91], uggest that prior or concomitant treatment of patients with nterferon alfa can sensitize LSCs to eradication by TKI therpy.”
BackgroundResultGhosh, D., Wikenheiser, D. J., Kennedy, B., McGovern, K. E., Stuart, J. D., Wilson, E. H., & Stumhofer, J. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502199 · Cited by 14
Aleksinskaya, M. A., Monge, M., Siebelt, M., Slot, E. M., Koekkoek, K. M., de Bruin, R. G., Massy, Z. A., Weinans, H., Rabelink, T. J., Fibbe, W. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33979-7 · Cited by 11
Heibl, S., Buxhofer‐Ausch, V., Schmidt, S. U., Webersinke, G., Lion, T., Piringer, G., Kuehr, T., Wolf, D. G. F., Melchardt, T., Greil, R., et al. (2020) · Hematological Oncology · doi:10.1002/hon.2786 · Cited by 11
Cell-Intrinsic WNT4 Promotes Hematopoietic Stem and Progenitor Cell Self-Renewal
Hétu-Arbour, R., Tlili, M., Ferreira, F. L. B., Abidin, B. M., Kwarteng, E. O., & Heinonen, K. M. (2021) · Stem Cells · doi:10.1002/stem.3385 · Cited by 11
Microbiota Signals Suppress B Lymphopoiesis With Aging in Mice
Krambs, J. R., Monlish, D. A., Gao, F., Schuettpelz, L. G., & Link, D. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767267 · Cited by 11
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
Rodriguez, J., Iniguez, A., Jena, N., Tata, P. V., Liu, Z., Lander, A. D., Lowengrub, J. S., & Etten, R. A. V. (2023) · eLife · doi:10.7554/elife.84149 · Cited by 12
Tortorella, S. M., Hung, A., & Karagiannis, T. C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6096 · Cited by 12
Modica, L., Iotti, G., D’Avola, A., & Blasi, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107916 · Cited by 11
Rendering the Leukemia Cell Susceptible to Attack
Sipkins, D. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmcibr0904291 · Cited by 13
Garza, A. D. L., Sinha, A. A., & Bowman, T. V. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0110 · Cited by 12
An Intrinsic Interferon Program Protects Stem Cells from Viral Infection
Haas, S. F., & Trumpp, A. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.01.013 · Cited by 11
Self-citationTip of the iceberg: roles of circRNAs in hematological malignancies.
Guo, S., Li, B., Zou, D., Yang, S.-J., Sheng, L., Ouyang, G., Mu, Q., & Huang, H. (2020) · PubMed Central · Cited by 13
Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial LocalizationPreprint
Ben‐Chetrit, N., Niu, X., Sotelo, J., Swett, A. D., Rajasekhar, V. K., Jiao, M. S., Stewart, C. M., Bhardwaj, P., Kottapalli, S., Ganesan, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563749 · Cited by 12
Human haematopoietic stem cells remember inflammatory stress
Zeng, A. G. X., Nagree, M. S., Jakobsen, N. A., Shah, S., Varesi, A., Kang, J. R. W., Murison, A., Cheong, J.-G., Turkalj, S., Zhang, X., et al. (2026) · Nature · doi:10.1038/s41586-026-10522-7 · Cited by 10
Filia, A., Mitroulis, I., Loukogiannaki, C., Grigoriou, M., Banos, A., Sentis, G., Giannouli, S., Karali, V., Athanasiadis, E. I., Kokkinopoulos, I., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1383358 · Cited by 10
Chae, D., Park, H. S., Kim, K.-M., Yu, A., Park, J. H., Oh, M., Choi, S. W., Ryu, J., Dunbar, C. E., Yoo, H. M., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01416-1 · Cited by 10
Rettkowski, J., & Cabezas‐Wallscheid, N. (2025) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101323-023806 · Cited by 15
Chen, M., Zheng, C., Zhang, Y., He, J., & Shi, Z. (2025) · Mediators of Inflammation · doi:10.1155/mi/9967975 · Cited by 10
Dunphy, G., Adán‐Barrientos, I., Fernández‐Delgado, I., Villarroya‐Beltri, C., Heras‐Murillo, I., Moya-Ruiz, E., Sánchez‐Álvarez, M., Jarit-Cabanillas, A., Pozo, M. Á. D., Guerra, S., et al. (2026) · Immunity · doi:10.1016/j.immuni.2025.12.010 · Cited by 12
Das, S., Kumar, A., Mandal, A., Abhishek, K., Verma, S., Kumar, A., & Das, P. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45800-0 · Cited by 11
Retracted
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.